20 May 2010
Hydrogel-coated coils for the treatment of cerebral aneurysms
Wojciech Poncyljusz, Aleksander Falkowski, Marcin Sawicki, Ireneusz Kojder, Robert JuszkatMed Sci Monit 2010; 16(1): 40-42 :: ID: 880581
Abstract
Background: The main goal was to assess aneurysm recurrence on follow-up angiography and clinical outcome at 12 to 18 months after coil placement.
Material/Methods: Eighty-two consecutive patients with a cerebral aneurysm (54 women and 28 men) aged from 32 to 71 years old (mean age, 56 years) were selected for intraarterial embolization in the anterior and posterior intracranial circulations and were treated with hydrocoils. The size of all aneurysms ranged from 2 to 26 mm in maximal diameter. We described aneurysms as small (≤7 mm), large (8–15 mm), very large (16–24 mm), and giant (≥25 mm).
Results: Hydrocoil coiling was successful in 97.6% (80). Balloon remodeling technique was used in 47.6% (39) patients and combined with Enterprise stent-coil embolization in 14.6% (12) other patients. The 12- to 18-month recurrence rate independent of the aneurysm size was 13.4% (11). The recurrence rate for small aneurysms was 3%, and the combined recurrence rate for small and large aneurysms was 8%. The combined recurrence rate for very large and giant aneurysms was 60%. The neurologic complication rate was 15%, of which 5% represented permanent neurologic deficits.
Conclusions: The hydrocoil embolization system is safe and provides excellent 12- to 18-month occlusion of small and large aneurysms. Very large and giant aneurysms are not as successfully occluded by this system.
Keywords: hydrogel-coated coils, cerebral aneurysms, embolization
Editorial
01 June 2025 : Editorial
Editorial: Harmonization and Publication of the 2025 Updates of the CONSORT and SPIRIT Statements for Clinical TrialsDOI: 10.12659/MSM.949923
Med Sci Monit 2025; 31:e949923
In Press
Clinical Research
Biomarker Discovery in Childhood Asthma: A Pilot Study of Serum Metabolite Analysis for IgE-Dependent AllergyMed Sci Monit In Press; DOI: 10.12659/MSM.948478
Review article
Antitumor Alkaloids in Tibetan Corydalis: Chemical Diversity and Pharmacological InsightsMed Sci Monit In Press; DOI: 10.12659/MSM.947268
Clinical Research
Differentiating Between Methylphenidate Use and Misuse: Clinical Insights From University Students and Acad...Med Sci Monit In Press; DOI: 10.12659/MSM.948984
Clinical Research
Six-Year Outcomes of CABG vs PCI in Diabetic Patients with Multivessel Coronary DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.948348
Most Viewed Current Articles
17 Jan 2024 : Review article 9,080,994
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,112
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 32,983
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 27,378
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912